Frequency of local recurrence following segmentectomy of stage IA non-small cell lung cancer is influenced by segment localisation and width of resection margins — implications for patient selection for segmentectomy

Sienel, Wulf; Stremmel, Christian; Kirschbaum, Andreas; Hinterberger, Louisa; Stoelben, Erich; Hasse, Joachim; Passlick, Bernward
March 2007
European Journal of Cardio-Thoracic Surgery;Mar2007, Vol. 31 Issue 3, p522
Academic Journal
Abstract: Objective: Segmentectomy has recently been suggested as alternative to lobectomy for curative treatment of early-stage non-small cell lung cancer (NSCLC). This study was performed to investigate if localisation of the resected segment or width of resection margins influence local recurrence following complete segmentectomy of stage IA NSCLC. Methods: Between 1987 and 2002, 49 segmentectomies and 150 lobectomies were performed in patients with pT1pN0cM0-NSCLC in our institution. Indications for segmentectomy were a limited pulmonary function or severe comorbidity. The median follow-up duration was 54 months. Local recurrence was distinguished from secondary primary lung cancer and was defined as tumour within the same lung or in the ipsilateral mediastinum. Segment localisation, width of resection margins, tumour size, tumour type, grading and age were analysed concerning their influence on local recurrence. Results: Local recurrence occurred in 16% of patients with segmentectomy and was significantly more frequent than in patients with lobectomy (5%; p =0.005; log-rank test). Segmentectomy in the S1–3 region tended more frequently to local recurrence than segmentectomy in the remaining segments (p =0.08; log-rank test): There was no recurrence following segmentectomy in the S7–10 region (n =6) or of S4–5 (n =5). Recurrence occurred in 7 (23%) out of 30 patients with segmentectomy in the S1–3 region and in 1 (12%) out of 8 patients with S6-segmentectomy. Also, resection margins≤1cm tended to be associated with local recurrence (p =0.06; log-rank test). Conclusions: The frequency of local recurrence following segmentectomy might be influenced by segment localisation and width of resection margins. Segmentectomy within the S1–3 region should be avoided whenever possible.


Related Articles

  • Küçük hücreli dışı akciÄŸer karsinomlarında preoperatif metastatik alt mediastinal lenf nodlarının saptanmasının saÄŸkalım üzerinde prognostik etkisi. Keskin, Hakan; Erdoğan, Abdullah; Zeybek, Arife; Dertsiz, Levent; Sarper, Alpay; Demircan, Abid // Journal of Clinical & Experimental Investigations / Klinik ve De;Dec2013, Vol. 4 Issue 4, p453 

    Objective: In our study, we reviewed the survival of patients operated for non-small cell lung cancer (NSCLC) and had positive inferior mediastinal lymph nodes that couldn't be staged with mediastinoscopy prior to surgery in comparison to other mediastinal lymph node involvement, the...

  • Anemia and Limited-stage Small Cell Lung Cancer. Ershler, William B. // Clinical Oncology Alert;Sep2007, Vol. 23 Issue 9, p65 

    There has been much written about the importance and management of anemia in cancer patients this past year. For certain tumors, it is clear that the appearance of anemia prior to therapy confers adverse prognostic implications.1-3 One aspect of the controversy surrounding anemia is whether...

  • Phase I clinical and pharmacokinetic study of 3-weekly, 3-h infusion of ixabepilone (BMS-247550), an epothilone B analog, in Japanese patients with refractory solid tumors. Shimizu, Toshio; Yamamoto, Noboru; Yamada, Yasuhide; Fujisaka, Yasuhito; Yamada, Kazuhiko; Fujiwara, Yutaka; Takayama, Kyoko; Tokudome, Takuto; Klimovsky, Judith; Tamura, Tomohide // Cancer Chemotherapy & Pharmacology;Apr2008, Vol. 61 Issue 5, p751 

    Ixabepilone (BMS-247550) is the first in a new class of anti-neoplastic agents, the epothilone analogs, and is a highly active non-taxane anti-microtubule agent. This phase I study aimed to determine the maximum tolerated dose (MTD), dose-limiting toxicities (DLTs), safety profile,...

  • Previous tumour as a prognostic factor in stage I non-small cell lung cancer. López-Encuentra, Angel; Gómez De Ia Cámara, Agustín; Rami-Porta, Ramón; Duque-Medina, José Luis; Martin De Nicolás, José Luis; Sayas, Javier // Thorax;May2007, Vol. 62 Issue 5, p386 

    Objective: To evaluate the effect of comorbidity as an independent prognostic factor in lung cancer. Method: Data on 2991 consecutive cases of lung cancer were collected prospectively from 19 Spanish hospitals between 1993 and 1997 by the Bronchogenic Carcinoma Cooperative Group of the Spanish...

  • Systemic Chemotherapy for Progression of Brain Metastases in Extensive-Stage Small Cell Lung Cancer. Abdel Karim, Nagla; Bhatt, Ananta; Chiec, Lauren; Curry, Richard // Case Reports in Oncological Medicine;8/28/2015, Vol. 2015, p1 

    Lung cancer is the most common cause of cancer related mortality in men and women. Approximately 15% of lung cancers are small cell type. Chemotherapy and radiation are the mainstay treatments. Currently, the standard chemotherapy regimen includes platinum/etoposide. For extensive small cell...

  • Stereotactic body radiation therapy for stage I non-small cell lung cancer: a small academic hospital experience. Witten, Matthew R.; Gittleman, Alicia E.; Catell, Donna T.; Haas, Jonathan A.; Factor, Oren B.; Vu, Charles C.; Schneider, Jeffrey G.; Schubach, Scott L. // Frontiers in Oncology;Oct2014, Vol. 4, p1 

    Purpose/Objective(s): Stereotactic body radiation therapy (SBRT) has been shown to have increased local control and overall survival relative to conventional external beam radiation therapy in patients with medically inoperable stage I non-small cell lung cancer (NSCLC). Excellent rates of local...

  • Prognostic significance of interleukin-17 in solid tumors: a meta-analysis. Yunhui Zeng; Qiongwen Zhang; Hong Wang; Minxun Lu; Hongyu Kong; Yingyi Zhang; Huashan Shi // International Journal of Clinical & Experimental Medicine;2015, Vol. 8 Issue 7, p10515 

    Background: The prognostic significance of intratumoral and peripheral interleukin-17 (IL-17) in tumors has been studied worldwide during these years, providing un-uniformed conclusions. Methods: We conducted a meta-analysis of published literatures that evaluated the correlation between IL-17...

  • How do patient and hospital features influence outcomes in small-cell lung cancer in England? Rich, A. L.; Tata, L. J.; Free, C. M.; Stanley, R. A.; Peake, M. D.; Baldwin, D. R.; Hubbard, R. B. // British Journal of Cancer;9/6/2011, Vol. 105 Issue 6, p746 

    Background:Our aim was to systematically determine how features of patients and hospitals influence access to chemotherapy and survival for people with small-cell lung cancer in England.Methods:We linked the National Lung Cancer Audit and Hospital Episode Statistics and used multiple logistic...

  • Socioeconomic position, stage of lung cancer and time between referral and diagnosis in Denmark, 2001-2008. Dalton, S O; Frederiksen, B L; Jacobsen, E; Steding-Jessen, M; Østerlind, K; Schüz, J; Osler, M; Johansen, C // British Journal of Cancer;9/27/2011, Vol. 105 Issue 7, p1042 

    Introduction:We investigated the association between socioeconomic position, stage at diagnosis, and length of period between referral and diagnosis in a nationwide cohort of lung cancer patients.Methods:Through the Danish Lung Cancer Register, we identified 18 103 persons diagnosed with lung...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics